Legend:
CC = Vancouver Convention Centre
F = Fairmont Waterfront Vancouver
* = applied session ! = JSM meeting theme
|
|
614 * !
|
Thu, 8/2/2018,
8:30 AM -
10:20 AM
|
CC-West 110
|
Reasonable Possibility - Statistical Science of Safety Monitoring — Topic Contributed Papers
|
Biopharmaceutical Section, Quality and Productivity Section
|
Organizer(s): Hal Li, Merck Research Laboratories
|
Chair(s): Judy Li, Regeneron Pharmaceuticals Inc.
|
8:35 AM
|
Beware On-Treatment Safety Analysis
Janet Wittes, Statistics Collaborative; Fred Yang, Innomed Consulting
|
8:55 AM
|
The Likelihood Principle and Its Application to Aggregate Safety Monitoring
LiAn Lin; Bill Wang, Merck
|
9:15 AM
|
Visual Analytics to Assess Reasonable Possibility: Using DILI as an Example
Kefei Zhou, Theravance Biopharma; Melvin Munsaka, AbbVie, Inc.; Krishan P. Singh, GlaxoSmithKline
|
9:35 AM
|
Practical Considerations in Planning and Implementing Aggregate Safety Monitoring
Bill Wang, Merck
|
9:55 AM
|
Floor Discussion
|